StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

Ataluren

HCID 11219835
Neue Reaktion
Drucken
GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
775304-57-9
Standard-SMILES
O=C(O)c1cccc(-c2noc(-c3ccccc3F)n2)c1
InChIKey
OOUGLTULBSNHNF-UHFFFAOYSA-N
Summenformel
C15H9FN2O3
Durchschnittliche Molmasse
284,24 g/mol
Monoisotopische Masse
284,05972037

Überblick

3-[5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl]benzoic acid is a ring assembly and an oxadiazole.

Namen und Bezeichner

Bevorzugter Name
Ataluren
IUPAC
3-[5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl]benzoic acid
Englischer Name
Ataluren
Summenformel
C15H9FN2O3
Molmasse
284.24

Namen und Synonyme

Ataluren775304-57-9PTC124PTC-1243-[5-(2-Fluorophenyl)-1,2,4-oxadiazol-3-yl]benzoic acid3-(5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl)benzoic acidTranslarnaK16AME9I3VAtalurenoDTXSID5046776Benzoic acid, 3-[5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl]-DTXCID3026776
Weitere Namen anzeigen
CS-749AtalureAtarulonAtaluren, >=98%
Benzoic acid, 3-(5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl)-atalurenumRefChem:560297M09AX03922-364-8Ataluren (PTC124)Ataluren [USAN]PTC 124

Datenbank-Bezeichner

CAS
775304-57-9
PubChem CID
11219835
DTXSID
DTXSID5046776
ChEMBL
CHEMBL256997
ChEBI
CHEBI:94805
UNII
K16AME9I3V
EC Number
695-053-5、922-364-8
Nikkaji
J2.446.661B

Eigenschaften

Berechnete Struktureigenschaften

XLogP
3,1
Polarare Oberfläche (TPSA)
76,2 Ų
H-Brücken-Donoren
1
H-Brücken-Akzeptoren
6
Frei drehbare Bindungen
3
Schwere Atome
21
Formalladung
0
Komplexität
382

Experimentelle und physikochemische Eigenschaften

Drugs · 2 Einträge

Pharmaceuticals -> Musculo-skeletal system -> Other drugs for disorders of the musculo-skeletal system

Pharmaceuticals -> Listed in ZINC15

Physikochemische Eigenschaften

Schmelzpunkt
241 · 241 - 242°C
Siedepunkt
503.7 · 503.7±60.0 °C(Predicted)
Dichte
1.379 · 1.379
storage temp.
Refrigerator
Löslichkeit
DMSO (Slightly)
Aggregatzustand
White to off-white solid.
pka
3.58 · 3.58±0.10(Predicted)
Farbe
White to Off-White
InChI
InChI=1S/C15H9FN2O3/c16-12-7-2-1-6-11(12)14-17-13(18-21-14)9-4-3-5-10(8-9)15(19)20/h1-8H,(H,19,20)
InChIKey
OOUGLTULBSNHNF-UHFFFAOYSA-N
SMILES
C(O)(=O)C1=CC=CC(C2N=C(C3=CC=CC=C3F)ON=2)=C1

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 3 Einträge

This chemical does not meet GHS hazard criteria for 100% (2 of 2) of all reports.

Not Classified

Aggregated GHS information provided per 2 reports by companies from 1 notifications to the ECHA C&L Inventory.

Gefahrenhinweise

Hazard Classes and CategoriesNot Classified

Sicherheitsdaten

wgk
WGK 3
hs_code
2933998090
Speicherklasse
11 - Combustible Solids
Hazard Classifications
STOT RE 2STOT SE 3

Chemie und Industrie

Pharmakologische Informationen

ATC Code · 2 Einträge

M - Musculo-skeletal system

QM - Musculo-skeletal system

Protein BindingAtaluren is 99.6% bound to human plasma proteins and the binding is independent of plasma concentration. Ataluren does not distribute into red blood cells.
Mechanism of Action · 1 Eintrag

Ataluren enables ribosomal readthrough of mRNA containing premature stop codons that otherwise would result in premature termination of protein chains. Use of ataluren allows cellular machinery to bypass nonsense mutations in genetic material, continue the translation process, and thereby restore the production of a full-length, functional protein. The research on the effects of Ataluren on the translation and stability of nonsense-containing mRNA in vitor show that Ataluren promoted readthrough at each of the nonsense codons, showing maximal activity with UGA, while having no effect on mRNA levels. Unlike the stable cell line assays, Ataluren did not discriminate significantly between the UAG and UAA mRNAs. Ataluren was a more potent nonsense-suppressing agent than gentamicin, and exhibited 4- to 15-fold stimulation of in vitro readthrough relative to the controls at levels similar to those in the stable cell reporter assays. These results indicate that Ataluren modulates termination efficiency at premature nonsense codons.

Biological Half-LifeAtaluren plasma half-life ranges from 2-6 hours and is unaffected either by dose or repeated administration.
Metabolism/Metabolites · 1 Eintrag

Ataluren is metabolized by conjugation via uridine diphosphate glucuronosyltransferase (UGT) enzymes, predominantly UGT1A9 in liver and intestine. In vivo, the only metabolite detected in plasma after oral administration of radio-labelled ataluren was the ataluren-O-1β-acyl glucuronide; exposure to this metabolite in humans was approximately 8% of the plasma AUC of ataluren.

Absorption, Distribution and Excretion · 2 Einträge

Peak plasma levels of ataluren are attained approximately 1.5 hours after dosing in subjects who received medicinal product within 30 minutes of a meal.

Zugehörige Reaktionen

21
Reaktionsaufzeichnung erstellen
Reaktionsgleichung von HRID 28526
HRID 28526als Produkt
Reaktionsgleichung von HRID 450700
HRID 450700als Produkt
Reaktionsgleichung von HRID 501224
HRID 501224als Produkt
Reaktionsgleichung von HRID 600760
HRID 600760als Edukt
Reaktionsgleichung von HRID 807054
HRID 807054als Edukt
Reaktionsgleichung von HRID 872254
HRID 872254als Produkt
Reaktionsgleichung von HRID 908658
HRID 908658als Produkt
Reaktionsgleichung von HRID 920883
HRID 920883als Edukt
ZurückSeite 1 von 3

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
CAS Datenbank
775304 · 775304-57-9

After a single oral dose of radiolabeled ataluren, approximately half of the administered radioactive dose is recovered in the faeces and the remainder was recovered in the urine. In the urine, unchanged ataluren and the acyl glucuronide metabolite account for less than 1% and 49%, respectively, of the administered dose.

Anwendungen · 2 Einträge

BeschreibungAtaluren is a drug marketed under the trade name Translarna® which was developed by PTC Therapeutics and approved by the European Union in May 2014 for the treatment of Duchenne’s muscular dystrophy (DMD) and potentially other genetic disorders. Ataluren renders ribosomes less sensitive to premature stop or ‘read-through’ codons, which are thought to be beneficial in diseases such as DMD and cystic fibrosis.

VerwendenNonsense mutations create a premature termination of mRNA translation and have been implicated in various genetic disorders, including muscular dystrophy and cystic fibrosis. PTC-124 is a nonaminoglycoside that has been reported to selectively induce ribosomes to read through premature nonsense stop signals on mRNA, thus allowing the production of full-length, functional proteins. In a mouse model of cystic fibrosis caused by nonsense mutations, PTC-124 treatment (60 mg/kg s.c. injection or 0.3-0.9 mg/ml orally) has been shown to restore cystic fibrosis transmembrane conductance regulator (CFTR) protein expression and function. The target activity of PTC-124 was initially evaluated by firefly luciferase reporter cell-based nonsense codon assay (IC50 = 7 nM); however, subsequent assessments using a Renilla reniformis luciferase reporter have failed to produce nonsense codon suppression activity. Thus, while PTC-124 is in clinical testing in patients with nonsense mutations within the CFTR or dystrophin genes, controversy surrounds its exact mechanism of action.[Cayman Chemical]

Vor- und nachgelagerte Produkte

Vorgelagerte Rohstoffe

5-(2-fluorophenyl)-3-(3-methylphenyl)-1,2,4-oxadiazole3-(Aminoiminomethyl)benzoic acid methyl esterMethyl 3-cyanobenzoateBenzoic acid, 3-[5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl]-, Methyl ester3-[(Hydroxyamino)iminomethyl]-benzoic acid3-Methylbenzenecarboximidamide hydrochloride2-Fluorbenzoesurem-CyanbenzoesureNatriumbromid2-Fluorbenzoylchlorid